Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Nov;84(5):1577–1587. doi: 10.1172/JCI114335

Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.

R Goldschmeding 1, C E van der Schoot 1, D ten Bokkel Huinink 1, C E Hack 1, M E van den Ende 1, C G Kallenberg 1, A E von dem Borne 1
PMCID: PMC304024  PMID: 2681270

Abstract

Anti-neutrophil cytoplasmic autoantibodies (ANCA) specifically associated with Wegener's granulomatosis were found to be directed against a saline-soluble glycoprotein triplet that migrates on SDS gels as distinct bands of Mr 29,000, 30,500, and 32,000 and is present in the azurophilic granules. This antigen was specifically recognized by all cytoplasmic-staining (C)-ANCA-positive sera from patients with Wegener's disease. C-ANCA antigen bound [3H]diisopropylfluorophosphate, which indicates that it is a serine protease, but it could clearly be distinguished from the serine proteases elastase and cathepsin G. Stimulation of cytochalasin B-treated neutrophils with FMLP induced release of C-ANCA antigen. This indicates that in vivo C-ANCA might interact with the C-ANCA antigen after its release upon inflammatory stimulation. We further demonstrate that in some perinuclear staining (P-ANCA) patients' sera autoantibodies against other myeloid lysosomal enzymes can be detected, such as antimyeloperoxidase and antielastase. C-ANCA and P-ANCA thus represent a novel class of autoantibodies directed against myeloid lysosomal enzymes. The originally described Wegener-specific C-ANCA show an apparently uniform specificity for the 29,000 serine protease. In contrast, P-ANCA may recognize myeloperoxidase as well as elastase and/or other antigens.

Full text

PDF
1586

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anti-neutrophil-cytoplasm antibodies in Wegener's granulomatosis are not directed against alkaline phosphatase. Lancet. 1987 Jun 27;1(8548):1488–1490. [PubMed] [Google Scholar]
  2. Anti-neutrophil-cytoplasm antibodies in Wegener's granulomatosis are not directed against alkaline phosphatase. Lancet. 1987 Jun 27;1(8548):1488–1490. [PubMed] [Google Scholar]
  3. Borregaard N., Heiple J. M., Simons E. R., Clark R. A. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol. 1983 Jul;97(1):52–61. doi: 10.1083/jcb.97.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davies D. J., Moran J. E., Niall J. F., Ryan G. B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? 1982 Aug 28-Sep 4Br Med J (Clin Res Ed) 285(6342):606–606. doi: 10.1136/bmj.285.6342.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DeRemee R. A., McDonald T. J., Weiland L. H. Wegener's granulomatosis: observations on treatment with antimicrobial agents. Mayo Clin Proc. 1985 Jan;60(1):27–32. doi: 10.1016/s0025-6196(12)65279-3. [DOI] [PubMed] [Google Scholar]
  6. Dewald B., Rindler-Ludwig R., Bretz U., Baggiolini M. Subcellular localization and heterogeneity of neutral proteases in neutrophilic polymorphonuclear leukocytes. J Exp Med. 1975 Apr 1;141(4):709–723. doi: 10.1084/jem.141.4.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Elder J. H., Alexander S. endo-beta-N-acetylglucosaminidase F: endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4540–4544. doi: 10.1073/pnas.79.15.4540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Falk R. J., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988 Jun 23;318(25):1651–1657. doi: 10.1056/NEJM198806233182504. [DOI] [PubMed] [Google Scholar]
  9. Fauci A. S., Haynes B. F., Katz P., Wolff S. M. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983 Jan;98(1):76–85. doi: 10.7326/0003-4819-98-1-76. [DOI] [PubMed] [Google Scholar]
  10. Fauci A. S., Wolff S. M. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore) 1973 Nov;52(6):535–561. doi: 10.1097/00005792-197311000-00002. [DOI] [PubMed] [Google Scholar]
  11. Feinstein G., Janoff A. A rapid method for purification of human granulocyte cationic neutral proteases: purification and characterization of human granulocyte chymotrypsin-like enzyme. Biochim Biophys Acta. 1975 Oct 22;403(2):477–492. doi: 10.1016/0005-2744(75)90076-5. [DOI] [PubMed] [Google Scholar]
  12. Feinstein G., Janoff A. A rapid method of purification of human granulocyte cationic neutral proteases: purification and further characterization of human granulocyte elastase. Biochim Biophys Acta. 1975 Oct 22;403(2):493–505. doi: 10.1016/0005-2744(75)90077-7. [DOI] [PubMed] [Google Scholar]
  13. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  14. Gross W. L., Lüdemann G., Kiefer G., Lehmann H. Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet. 1986 Apr 5;1(8484):806–806. doi: 10.1016/s0140-6736(86)91820-9. [DOI] [PubMed] [Google Scholar]
  15. Huisman J. G., Winkel I. N., Lelie P. N., Tersmette M., Goudsmit J., Miedema F. Detection of early anti-p24 HIV responses in EIA- and immunoblot-negative individuals. Implications for confirmatory testing. Vox Sang. 1987;53(1):31–36. doi: 10.1111/j.1423-0410.1987.tb04910.x. [DOI] [PubMed] [Google Scholar]
  16. Kao R. C., Wehner N. G., Skubitz K. M., Gray B. H., Hoidal J. R. Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest. 1988 Dec;82(6):1963–1973. doi: 10.1172/JCI113816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lockwood C. M., Bakes D., Jones S., Whitaker K. B., Moss D. W., Savage C. O. Association of alkaline phosphatase with an autoantigen recognised by circulating anti-neutrophil antibodies in systemic vasculitis. Lancet. 1987 Mar 28;1(8535):716–720. doi: 10.1016/s0140-6736(87)90357-6. [DOI] [PubMed] [Google Scholar]
  18. Lüdemann G., Gross W. L. Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis. Clin Exp Immunol. 1987 Aug;69(2):350–357. [PMC free article] [PubMed] [Google Scholar]
  19. Martodam R. R., Baugh R. J., Twumasi D. Y., Liener I. E. A rapid procedure for the large scale purification of elastase and cathepsin G from human sputum. Prep Biochem. 1979;9(1):15–31. doi: 10.1080/00327487908061669. [DOI] [PubMed] [Google Scholar]
  20. McCluskey R. T., Fienberg R. Vasculitis in primary vasculitides, granulomatoses, and connective tissue diseases. Hum Pathol. 1983 Apr;14(4):305–315. doi: 10.1016/s0046-8177(83)80116-6. [DOI] [PubMed] [Google Scholar]
  21. Pinching A. J., Rees A. J., Pussell B. A., Lockwood C. M., Mitchison R. S., Peters D. K. Relapses in Wegener's granulomatosis: the role of infection. Br Med J. 1980 Sep 27;281(6244):836–838. doi: 10.1136/bmj.281.6244.836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pulford K. A., Erber W. N., Crick J. A., Olsson I., Micklem K. J., Gatter K. C., Mason D. Y. Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells. J Clin Pathol. 1988 Aug;41(8):853–860. doi: 10.1136/jcp.41.8.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Savage C. O., Winearls C. G., Jones S., Marshall P. D., Lockwood C. M. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet. 1987 Jun 20;1(8547):1389–1393. doi: 10.1016/s0140-6736(87)90591-5. [DOI] [PubMed] [Google Scholar]
  24. Sweetman F., Ornstein L. Electrophoresis of elastase-like esterases from human neutrophils. J Histochem Cytochem. 1974 May;22(5):327–339. doi: 10.1177/22.5.327. [DOI] [PubMed] [Google Scholar]
  25. Verheugt F. W., von dem Borne A. E., Décary F., Engelfriet C. P. The detection of granulocyte alloantibodies with an indirect immunofluorescence test. Br J Haematol. 1977 Aug;36(4):533–544. doi: 10.1111/j.1365-2141.1977.tb00994.x. [DOI] [PubMed] [Google Scholar]
  26. Voetman A. A., Weening R. S., Hamers M. N., Meerhof L. J., Bot A. A., Roos D. Phagocytosing human neutrophils inactivate their own granular enzymes. J Clin Invest. 1981 May;67(5):1541–1549. doi: 10.1172/JCI110185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. West B. C., Todd J. R., King J. W. Wegener granulomatosis and trimethoprim-sulfamethoxazole. Complete remission after a twenty-year course. Ann Intern Med. 1987 Jun;106(6):840–842. doi: 10.7326/0003-4819-106-6-840. [DOI] [PubMed] [Google Scholar]
  28. Wiik A. Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy. 1980 Jun;35(4):263–289. doi: 10.1111/j.1398-9995.1980.tb01768.x. [DOI] [PubMed] [Google Scholar]
  29. van der Schoot C. E., Wester M., Von Dem Borne A. E., Huisman H. G. Characterization of platelet-specific alloantigens by immunoblotting: localization of Zw and Bak antigens. Br J Haematol. 1986 Dec;64(4):715–723. doi: 10.1111/j.1365-2141.1986.tb02233.x. [DOI] [PubMed] [Google Scholar]
  30. van der Woude F. J., Arisz L., Meijer S., Donker A. J., Hoedemaeker P. J., van Overbeek J. J. Wegener's granulomatosis. A clinicopathological study in twelve patients. Neth J Med. 1978;21(5):205–220. [PubMed] [Google Scholar]
  31. van der Woude F. J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L. A., van der Giessen M., van der Hem G. K., The T. H. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES